Stocks in play: Antibe Therapeutics Inc.
Is extending the Early Warrant Exercise Incentive Program for its 6.4 million outstanding and unlisted share purchase warrants having an exercise price of $1.50 and expiring on July 31, 2024. Antibe Therapeutics Inc. shares T.ATE are trading unchanged at $1.01.
Read:
Innovative Strategies in the Fight Against Pancreatic Cancer: A 2023 Recap
Lithium M&A Activity Heats Up Again on New Deals in Argentina’s Lithium Triangle
South America's Lithium Potential Sparks Global Competition Amid Renewable Energy Push
South America's Lithium Potential Sparks Global Competition Amid Renewable Energy Push